Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2

NCT04525417 is registered in ClinicalTrials.gov with Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux as lead sponsor.

NCT NCT04525417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04525417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2
Lead sponsor
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2020
Completion date
October 25, 2020
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 immune status of healthcare workers